GC20190
Bimekizumab
Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F· Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation· Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation[1]
ChemicalCAS1418205-77-2
- CAS number
- 1418205-77-2
- Molecular weight
- —
- Formula
- —
- Catalogue number
- GC20190
- Brand
- GLPBIO
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il